StockData
Nuo Therapeutics, Inc. logo

Nuo Therapeutics, Inc. (AURX) stock

AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$1.26−0.04 (-3.08%)

Close on Oct 19, 2026Market cap $60.99MP/E –Yield –

Nuo Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Nuo Therapeutics's pe ratio was 0.0× on Jan 31, 2022, against 48.0× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jan 31, 20220.0×+0.0
2021Dec 31, 20210.0×−54.3
2020Dec 31, 202054.3×–

More Nuo Therapeutics figures

See a number that looks wrong?